[RACP LIFT] What you need to know about metabolic dysfunction-associated fatty liver disease

episode

Previously titled “[RACP Lift] What you need to know about metabolic dysfunction-associated fatty liver disease” — renamed by the publisher on Aug 3, 2026

Pomegranate Health not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Start A Blessing | Joel Osteen 31 min · 29 Sep 2026 · Joel Osteen Podcast

Peter O'Mahony in studio | Why Munster need big changes, Joe & Andy, mouthy Scotland 59 min · 29 Sep 2026 · Indo Sport

Ari Emanuel: What Hollywood’s Ultimate Power Broker Knows About Succeeding Against the Odds 51 min · 29 Sep 2026 · Aspire with Emma Grede

NPR News: 09-29-2026 8AM EDT 5 min · 29 Sep 2026 · NPR News Now

EP 130: Gerry Hopkinson Sold His Agency, Stayed Five Years, And Became A Cultural Strategist 56 min · 29 Sep 2026 · Embracing Marketing Mistakes

Louise Kennedy 24 min · 29 Sep 2026 · The Waterstones Podcast

Report any issue

Source

Recorded30 Jun 2026

Publisherfeeds.buzzsprout.com

Handlerec:19120873

Show notes

This episode is a teaser for RACP LIFT 2026, a series of in-person events to promote Learning, Innovation and Forward Thinking. Coming up on the 1st of August in Melbourne there will be a Rapid Fire Clinical Update on Respiratory medicine, infectious diseases and critical illness. And on the 20th In Brisbane another one themed around Palliative medicine and also population health. In March, the Sydney RACP offices hosed a meeting on cardiometabolic and vascular health, and the talk shared here covers everything a generalist needs to know about metabolic dysfunction-associated fatty liver disease. The seminar was presented by Professor Jacob George, Director of the Storr Liver Centre at the Westmead Institute for Medical Research, and author of over 1300 peer-reviewed papers. He explains why fatty liver disease is a "canary in the coal mine" for metabolic health more generally, how to diagnose using scans and bloods, and the use of the FIB-4 index. Professor George also describes how patients can be stratified and managed for risk of more complex liver disease and reviews outcomes from the latest pharmacological interventions. GuestsProfessor Jacob George FRACP PhD FAASLD (The Westmead Institute for Medical Research, Centre Director; University of Sydney)Chapters 3:09 MAFLD is a positive definition 4:29 How common are MAFLD and MASH? 5:58 How do you define metabolic health? 9:02 Mortality and cardiovascular outcomes in patients with T2D 10:07 MAFLD in primary care guideline 12:40 Current and future therapies for MAFLD / MASH 15:24 Management algorithm for MAFLD 16:50 Test your knowledgeProductionRapid Fire Clinical Update developed by LIFT advisory group and hosted/recorded by RACP Events team and. Podcast production by Mic Cavazzini DPhil. Music licenced from Epidemic Sound includes ‘Kryptonite’ by Blue Steel and ‘Simmering Anxiety’ by Christian Andersen and ‘Little Liberty’ by Paisely Pink. Visit the Pomegranate Health web page for a transcript and supporting references. Add educational activity to MyCPD. Subscribe through any podcasting app or our email alerts list.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related